Exploring the Impact of Leishmania Major on Mesenchymal Stem Cells: Evaluating Differentiation, and Immunomodulatory

Elham Mashayekh1, Arezou Khosrojerdi2, Ahmad Zavaran Hosseini3

  • 11 Department of Immunology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran. elhammashayekh1372@gmail.com.

Insights

Mesenchymal stem cells (MSCs) engulf Leishmania major parasites, increasing toll-like receptor (TLR) expression and reactive oxygen species. This exposure diminishes MSCs' immunomodulatory capacity, impacting their therapeutic use in parasitic infections.

Area of Science:

  • Immunology
  • Stem Cell Biology
  • Parasitology

Background:

  • Pathogen recognition receptors (PRRs), including toll-like receptors (TLRs), modulate mesenchymal stem cell (MSC) functions.
  • PRR activation can alter MSC surface markers, differentiation potential, and secreted factors, potentially affecting therapeutic outcomes.
  • The impact of Leishmania major (L. major) infection on MSC properties requires detailed investigation.

Purpose of the Study:

  • To investigate the effects of L. major promastigotes on the functional characteristics of adipose tissue-derived MSCs.
  • To analyze changes in TLR expression, surface marker profiles, and cytokine secretion following parasite exposure.
  • To assess the implications of these alterations on the immunomodulatory capacity of MSCs.

Main Methods:

  • Isolation and culture of adipose tissue-derived MSCs.
  • Exposure of MSCs to L. major promastigotes and quantification of parasite engulfment via Giemsa staining.
  • Assessment of TLR and surface marker expression using real-time PCR and flow cytometry.
  • Measurement of reactive oxygen species and cytokine levels.

Main Results:

  • MSCs successfully engulfed L. major parasites.
  • Increased expression of TLR4 and TLR6 was observed in MSCs post-exposure.
  • Pro-inflammatory cytokine levels rose, while transforming growth factor-β decreased.
  • Parasite exposure led to elevated reactive oxygen species production and down-regulation of CD29 and CD73 surface markers.

Conclusions:

  • L. major infection significantly alters MSC phenotype and function, including increased TLR expression and reduced immunomodulatory capacity.
  • These changes, particularly the diminished ability to modulate immune responses, have critical implications for the therapeutic application of MSCs in leishmaniasis.
  • Further research is warranted to understand and potentially mitigate these effects for improved MSC-based therapies against parasitic diseases.